動画検索
関連広告
検索結果
Multimodality targeting of MM in the context of the BM microenvironment
Rational combination strategies in MM
Lenalidomide/Bortezomib-Based Rx in NDMM
Open-label, non-randomized phase 1/2 study of twice-weekly bazomib+ Rd in NDMM
Phase III: IFM 2009: Adverse Events
PFS in Expanded High-risk Patients
Elotuzumab: Immunostimulatory Mechanism of Action
Phase II CASTOR Study: DVd vs. Vd (n=498) .
Phase lb Study of Isatuximab+Pom+dex in RRMM (n-20)
DREAMM 1 Part 2: Duration of Study Treatment by Response